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Background: To retrospectively analyze the imaging characteristics, techniques, and outcome in patients who underwent endovascular treatment for
pancreatitis-related pseudoaneurysms.
Methods: The study included 38 patients with pancreatitis who had pseudoaneurysm as a complication and who had been treated by endovascular
methods between 2000 and 2013. Of the 38 patients, 24 (male:female ¼ 21:3; average age 41.5 years) had imaging features of chronic pancreatitis.
Fourteen patients (male:female ¼ 12:2; average age 54.9 years) had features of acute pancreatitis. Computed tomography and digital subtraction
angiography features of the pseudoaneurysms, endovascular technique and outcome in these patients were analyzed.
Results: The average size of pseudoaneurysms inpatients with acute pancreatitis was 24.2mmand 24.7mm in thosewith chronic pancreatitis. No statistically
signiﬁcant (P ¼ 0.913) difference in size was noted. Pseudoaneurysms in patients with chronic pancreatitis had more well-deﬁned and thicker walls (average
wall thickness 18.1 mm). Coil embolization was performed in 26 patients (68.4%). N-butyl cyanoacrylate embolization was done in ﬁve patients (13.1%). A
covered stent was used in one patient (2.6%). A combination of techniqueswas used in ﬁve patients (13.1%) and gelfoam embolization alonewas performed in
one patient (2.6%). Technical success was achieved in 37 patients (97.3%). Reinterventionwas done in one patient. Themean imaging follow-up timewas 10.74
months (3 days–84 months) and was available in 35 patients (92.1%). One patient died because of sepsis related to pancreatitis.
Conclusion: Endovascular treatment is an effective ﬁrst line of management in pancreatic pseudoaneurysms. The endovascular technique depends on the
vascular location and morphological features of the pseudoaneurysm.
Copyright  2014, Society of Gastrointestinal Intervention. Published by Elsevier.
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The occurrence of vascular complications in the form of pseu-
doaneurysm of visceral arteries is reported to range from 1.2% to
14% with a higher incidence in chronic pancreatitis (7–10%) than in
acute pancreatitis (1–6%).1,2 Pseudoaneurysms can cause lethal
hemorrhage and the mortality in untreated patients can be as high
as 90%.3 Hence it becomes important to recognize and treat these
patients as early as possible irrespective of the size of the pseu-
doaneurysm and patient’s symptoms. Endovascular techniques
with success rates of 79–100% have replaced surgery as the ﬁrst line
of management in these patients.4,5 Because of the low overall
incidence of pseudoaneurysms and the need to achieve rapid he-
mostasis, randomized control trials of therapeutic options are not
possible.
The published data regarding pancreatitis-related pseudoa-
neurysms is limited to review articles and short case series. The
largest published study is of 104 cases in which endovascularDepartment of Radiology, Amrita Institute of Medical Sciences, Ponekkara, Cochin, Kerala, In
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knowledge, this present study is the largest single-center series of
pancreatitis-related pseudoaneurysms treated by endovascular
methods. The purpose of the study was to retrospectively analyze
the imaging characteristics, techniques and outcome in patients
presenting with pancreatitis-related pseudoaneurysms who un-
derwent endovascular treatments. The study also aims to compare
the morphological features of pseudoaneurysms in acute and
chronic pancreatitis to identify features which may impact the
endovascular technique.Methods
Patient population
Institutional review board approval was obtained for this
retrospective analysis. We retrieved the hospital records of 1150dia
es and Research Centre, Amrita Lane, Ponekkra, Elamakkara, Kochi 682026, Kerala,
ni).
vier. Open access under CC BY-NC-ND license.
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pseudoaneurysm as a complication and treated by endovascular
methods between 2000 and 2013. Clinical records and images were
retrieved from electronic medical records and picture archiving and
communication systems.
Of the total 38 patients, 24 (male:female ¼ 21:3) had back-
ground imaging features of chronic pancreatitis and ranged in
age from 15 years to 84 years (mean  SD ¼ 41.5  17.5). Of these
24 patients, 6 (25%) were 30years. Fourteen patients
(M:F ¼ 12:2) had features of only acute pancreatitis and ranged
in age from 34 years to 73 years (mean  SD ¼ 54.9  10.5). The
majority of patients (16/24; 66.6%) with a background of chronic
pancreatitis presented with evidence of gastrointestinal
bleeding, six (25%) presented with only acute abdominal pain
and two (8.3%) had no symptoms. The majority of patients with
acute pancreatitis presented with only acute pain abdomen (10/
14; 71.4%) whereas four (28.5%) presented with evidence of
gastrointestinal bleeding.
Imaging and intervention technique
In the period 2000–2005, our patients were imaged with single
slice spiral computed tomography (CT). From 2005 onwards we had
used 64-slice CT to perform triple phase CT prior to the procedure
in all patients. Initial plain CT of upper abdomen was done to
identify calciﬁcations or hematoma and subsequently contrast-
enhanced images were obtained in the arterial phase and venous
phase. Presence of parenchymal atrophy, duct dilatation, paren-
chymal calciﬁcation or intraductal calculi on CT were considered as
features of chronic pancreatitis7 (Fig. 1). Tropical pancreatitis was
diagnosed in young patients (<30 years) with typical imaging and
clinical features.5,6
Digital subtraction angiography (DSA) was performed through
femoral artery access in all patients using a 5F Simmons 1 or
Chuang 2 catheter (Cook, Bloomington, IN, USA). Superselective
catheterization was achieved with a coaxially introduced 3F
microcatheter (Progreat, Terumo, Tokyo, Japan orMicroferret, Cook,
Blomington, IN, USA) and embolization performed with pushable
steel coils (Tornado, Cook), N-butyl cyanoacrylate (NBCA, lipiodol
and NBCA mixture of 15–20%) or gelfoam. The coaxial technique
was used in all patients. In one patient a large pseudoaneurysmFig. 1. A 40-year-old female with chronic calciﬁc pancreatitis presented with hema-
temesis. Contrast-enhanced computed tomography shows multiple intraductal and
intraparenchymal calciﬁcations in the head region (white arrow). Pseudocyst (large
arrowhead) in tail region with hyperdense content within, suggestive of clot (small
arrowhead). Note splenic artery (small arrow) traversing through the inferior wall of
the pseudocyst. Digital subtraction angiography (not shown) conﬁrmed a rent in the
splenic artery which was treated by coil trapping.arising from the superior mesenteric artery (SMA) trunk was suc-
cessfully treated by deploying a covered stent (Gore, Viabahn,
Flagstaff, AZ, USA) from a brachial approach. Percutaneous injection
of NBCAwas done using Chiba needle (Cook, Bloomington, IN, USA)
under ultrasound guidance.
Analysis
Primary end points: (1) technical success, deﬁned as successful
exclusion of pseudoaneurysm from systemic circulation, conﬁrmed
by DSA at end of procedure; (2) target lesion reintervention was
deﬁned as requiring an additional procedure (surgical or percuta-
neous) due to reperfusion of pseudoaneurysm; and (3) periproce-
dural mortality was deﬁned as death occurring within 1 month of
the procedure. Secondary end points were major or minor com-
plications deﬁned as per international reporting standards.8
Follow-up imagingwasdonewith either aDoppler study, contrast
enhanced CT or DSA. Statistical analysis was performed using IBM
SPSS Statistics 20.0 software. The data were analyzed using descrip-
tive statisticalmethods. Comparison between groupswas done using
the Mann–Whitney U test and Wilcoxon signed-rank test.
Results
Morphological features of pseudoaneurysms
The site of origin of pseudoaneurysms in acute pancreatitis and
inpatientswith background chronic pancreatitis is shown inTable 1.
In both groups the splenic artery (SA) was the most common artery
of origin. The average size of the pseudoaneurysm in acute
pancreatitis patients as measured using CT was 4–43 mm
(24.2  13.8 mm) and in patients with background chronic
pancreatitis was 2–50 mm (24.7  13.8 mm). Comparing sizes of
pseudoaneurysms in acute and background chronic pancreatitis
patients using the Mann-Whitney U test, showed no statistically
signiﬁcant (P ¼ 0.913) difference in size of pseudoaneurysms be-
tween the two groups.
We also noticed that a large proportion of pseudoaneurysms
(12/24; 50%) in patients with background chronic pancreatitis had
thicker walls (average wall thickness 18.1 mm), whereas in acute
pancreatitis, pseudoaneurysms had imperceptible walls. The
average size of pseudoaneurysm in these 12 patients as measured
using CT was 36.3 6.3 mm and 18.2 3.3 mm on DSA. ComparingTable 1 Artery of Origin in Patientswith Acute Pancreatitis and in Patientswith
Background Chronic Pancreatitis
Patients with acute pancreatitis
Site of pseudoaneurysm Number of patients (n ¼ 14)
SA 4 (28.5%)
IPDA 4 (28.5%)
GDA 3 (21.4%)
SMA 1 (7.1%)
Jejunal branch of SMA 2 (14.2%)
Patients with background chronic pancreatitis
Site of pseudoaneurysm Number of patients (n ¼ 24)
SA 11 (45.8%)
GDA 4 (16.6%)
IPDA 3 (12.5%)
CHA 2 (8.3%)
DPA 1 (4.1%)
SPDA 1 (4.1%)
LHA 1 (4.1%)
CHA, common hepatic artery; DPA, dorsal pancreatic artery; GDA, gastroduodenal
artery; IPDA, inferior pancreatico duodenal artery; LHA, left hepatic artery; SA,
splenic artery; SMA, superior mesenteric artery; SPDA, superior pancreatico
duodenal artery.
Table 2 Technique of Endovascular Management in Patients with Acute
Pancreatitis and in Patients with Background Chronic Pancreatitis
Technique of endovascular management in patients with acute pancreatitis
Artery of origin Size (mm) Technique of embolization
IPDA 4 Coil trapping
IPDA 8.5 Coil trapping and N-butyl cyanoacrylate
embolization
GDA 5 Coil trapping
IPDA 15 Coil trapping
GDA 40 Inﬂow occlusion
IPDA 39 Coil trapping and gelfoam embolization
SA 10 Coil trapping and N-butyl cyanoacrylate
embolization
SA 22 Coil trapping
SA 30 Coil trapping
Jejunal branch
of SMA
30 Gelfoam injection
Jejunal branch
of SMA
22 Inﬂow occlusion
SA 40 Coil trapping and gelfoam embolization.
GDA 43 Coiling and percutaneous N-butyl
cyanoacrylate injection into
pseudoaneurysm
SMA 30 Covered stent
Technique of endovascular management in patients with background chronic
pancreatitis
Artery of origin Size (mm) Technique of embolization
IPDA 32 Intra-operative ultrasound guided
direct NBCA injection into
pseudoaneurysm
SA 36 Coil trapping
SA 15 Coil trapping
DPA 11 Coil trapping
CHA 18 Coil trapping
GDA 2 Coil trapping
SA 20 Coil trapping
GDA 10 Coil trapping
GDA 38 Coil trapping
SA 40 Coil trapping
SPDA 30 Intra-arterial NBCA embolization
SA 36 Coil trapping
SA 18 Coil trapping
SA 6 Coil trapping
SA 28 Coil trapping
SA 2 Coil trapping
Jejunal branch
of SMA
29 Coil trapping
SA 45 Inﬂow occlusion
CHA 24 Coil trapping
LHA 11 Intra-arterial NBCA embolization
IPDA 35 Coil trapping
IPDA 50 Coil trapping
GDA 32 NBCA injection into pseudoaneurysm
through microcatheter tip within
pseudoaneurysm
SA 20 Intra-arterial NBCA embolization
CHA, common hepatic artery; DPA, dorsal pancreatic artery; GDA, gastroduodenal
artery; IPDA, inferior pancreatico duodenal artery; LHA, left hepatic artery; SA,
splenic artery; SMA, superior mesenteric artery; SPDA, superior pancreatico
duodenal artery.
Table 3 Technique of Endovascular Management
Technique of embolization Acute
pancreatitis
(n ¼ 14)
Background chronic
pancreatitis
(n ¼ 24)
Total (n ¼ 38)
Coil trapping 5 18 23 (60.5%)
Combined coiling and NBCA
or gelfoam embolization
5 0 5 (13.1%)
NBCA embolization 0 5 5 (13.1%)
Inﬂow occlusion 2 1 3 (7.8%)
Covered stent 1 0 1 (2.6%)
Gelfoam embolization 1 0 1 (2.6%)
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test showed a statistically signiﬁcant difference (P ¼ 0.002).
Treatment technique
Coil embolization was the most common technique used in
treating pseudoaneurysms (26/38; 68.4%). Coil trapping, which is
isolating the pseudoaneurysm by coil embolization from both ends
of the arcade was done in 23 patients. Inﬂow occlusion was per-
formed in three patients.
NBCA was used when coil trapping was not possible or when
there was lack of intra-arterial access either as a result of
anatomical location or previous embolization. Percutaneous or
transcatheter NBCA injection alone was done in 5/38 (13.1%) and
all ﬁve patients had background chronic pancreatitis with thick-
walled pseudoaneurysms. In four patients [superior pancreatico-
duodenal artery (SPDA), left hepatic artery (LHA), splenic artery
(SA), gastroduodenal artery (GDA) pseudoaneurysms] NBCA in-
jection was done after achieving a safe microcatheter position
either close to or inside the pseudoaneurysm. In a patient with
an inferior pancreatico-duodenal artery (IPDA) pseudoaneurysm,
an initial attempt to embolize the pseudoaneurysm using NBCA
failed as the injected NBCA was shunted into the portal radicals
through an arterio-portal ﬁstula. The patient had pre-existing
portal cavernoma and the pseudoaneurysm had ruptured into
one of the portal collateral channels. The patient was taken for
surgery and direct injection of NBCA into the pseudoaneurysm
was done intraoperatively under ultrasound guidance. Two-year
follow-up ultrasound showed no reperfusion of
pseudoaneurysm.
Combination of coiling and transcatheter or percutaneous
NBCA embolization was used in 3/38 (7.8%) patients (IPDA, GDA,
and SA pseudoaneurysms). In a patient with GDA pseudoaneur-
ysm, after coiling the feeder from the GDA, the pseudoaneurysm
continued to ﬁll from tiny branches of the IPDA, which were not
suitable for catheterization. Percutaneous injection of NBCA into
the pseudoaneurysm was done under ultrasound guidance to
complete the treatment. In another patient, after coiling of the
main artery, the SA pseudoaneurysm continued to ﬁll from distal
small branches of the dorsal pancreatic artery. NBCA was injected
into the dorsal pancreatic artery from a relatively proximal posi-
tion of the microcatheter. Combined coiling and gelfoam emboli-
zation was performed in 2/38 (5.2%) patients (IPDA and SA
pseudoaneurysms). In one patient (2.6%) a large pseudoaneurysm
arising from the SMA trunk was successfully treated by deploying
a covered stent across the neck of pseudoaneurysm. Post-
procedure the SMA was patent and there was no reperfusion of
the pseudoaneurysm (Tables 2, 3).
Technical outcome and complications
The procedural technical success was achieved in 37 of 38
patients (97.3%). In a patient with SA pseudoaneurysm treated
with an inﬂow occlusion technique, the immediate post-
procedure DSA showed no perfusion of the pseudoaneurysm.
However, 1 month later, CT showed reperfusion of the pseudoa-
neurysm. No reintervention was attempted because of lack of ac-
cess to the pseudoaneurysm and patient had to undergo SA
ligation and splenectomy.
Procedure-related complications occurred in two patients. In a
patient with an IPDA pseudoaneurysm, even though isolation was
achieved by coil trapping, one of coils prolapsed in the proper he-
patic artery. However, the hepatic artery remained patent (Fig. 2).
In another patient with splenic artery pseudoaneurysm treated
with intra-arterial NBCA injection, NBCA spilled into distal splenic
artery branches leading to a large splenic infarct.
Fig. 2. A 29-year-old male with chronic pancreatitis presented with hematemesis. (A) Contrast-enhanced computed tomography shows a large pseudoaneurysm with peripheral
thrombus in the pancreatic head region (arrowheads). (B) Selective digital subtraction angiography shows the pseudoaneurysm (arrowhead) arising from the inferior pancreatico
duodenal artery (IPDA) with an additional supply from the GDA (arrows). (C) Feeders from both arteries accessed through the IPDA and coil-embolized (arrows). Complete isolation
of the pseudoaneurysm achieved. Note prolapse of one of the coils into proper hepatic artery (C, black arrow); however, the artery is patent.
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Follow-up imaging was done with either a Doppler study,
contrast enhanced CT, or DSA. The postprocedure mean time of
follow-up was 10.7  22.5 months (3 days–84 months) and was
available in 35 of 38 patients (92.1%). One patient died 15 days after
the endovascular procedure. The cause of death was sepsis related
to pancreatitis. There were no occurrences of bowel ischemia, he-
patic insufﬁciency, or rupture-related deaths in any of patients in
the follow-up period.Fig. 3. A 35-year old male with chronic pancreatitis presented with hematemesis. (A) Contra
shows the pseudoaneurysm (B, arrowhead) arising from distal splenic artery (A, arrow). (C) D
(arrow). (D) Contrast-enhanced CT 1 month later shows reperfusion of the pseudoaneurysmDiscussion
Pancreatitis is a challenging clinical problem requiring repeated
imaging to monitor the progression of disease and to detect the
complications. Early detection and prompt treatment of vascular
complications is essential because of the high rate of mortality in
untreated patients.3 Recent advances in the MDCT has enabled early
detection of vascular complications and provides a clear road map
for endovascular therapy. In this study we retrospectively analyzed
the imaging characteristics, techniques of endovascular treatment,st-enhanced computed tomography (CT) and (B) celiac digital subtraction angiography
istal access was not achieved and only the proximal splenic artery was coil-embolized
(arrowhead).
Fig. 4. A 35-year-old male with chronic pancreatitis presented with recurrent abdominal pain. Contrast-enhanced computed tomography and digital subtraction angiography
shows the pseudoaneurysm (A, arrow) arising from GDA origin (B, arrow). (C) As distal access was not achieved and there was only a short stump, direct injection of N-butyl
cyanoacrylate into pseudoaneurysm done with the microcatheter tip positioned within the pseudoaneurysm (arrow). (D) Note the reﬂux of glue into the distal feeders (arrow). (E)
Complete isolation of pseudoaneurysm achieved (arrow).
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neurysms and also compared the morphological features of pseu-
doaneurysms in acute and chronic pancreatitis in order to identify
features which may impact the endovascular technique.
CT can be performed quickly and has a high reported accuracy
in detecting arterial complications.9 Multidetector computed to-
mography (MDCT) accurately localizes the pseudoaneurysm and
its arterial supply, identiﬁes the difﬁcult angle of origin or an
anomalous origin of artery allowing us to draw up a clear strategy
for the approach and which embolization technique to use, before
the procedure. DSA allows imaging in real time, helping to
correctly identify the artery of origin and assess the collateral
circulation.9 Abdominal angiography has been reported to detect
the source of bleeding in 94% of patients.7 We observed that DSA
underestimates the size of an pseudoaneurysm with the periph-
eral thrombus visualizing only the patent lumen whereas CT im-
aging show the lumen and the peripheral thrombus and thus the
actual size of the pseudoaneurysm can be determined. Pseudoa-
neurysms in pancreatitis are secondary to inﬂammatory
destruction of wall or due to bleeding into the pseudocyst. The
wall visible on CT represents only a covering of thrombus, in-
ﬂammatory, or ﬁbrous tissue. We also noticed that a largeFig. 5. A 64-year-old male with chronic pancreatitis presented with melaena. (A) Selective
from the Inferior pancreatico duodenal artery. An initial attempt to embolize with N-buty
formed intra-operatively by direct injection of N-butyl cyanoacrylate into the pseudoaneury
no reperfusion of pseudoaneurysm (arrowhead). Note glue cast in small intrahepatic portaproportion of pseudoaneurysms (12/24; 50%) in patients with
background chronic pancreatitis had thicker walls (average wall
thickness 18.1 mm), whereas in acute pancreatitis, pseudoaneur-
ysms had imperceptible walls (Fig. 2).
We had a unique subset of the population with tropical
pancreatitis. Tropical pancreatitis is a unique early onset (<30
years) calciﬁc pancreatitis of unknown etiology prevalent in many
tropical countries.10,11 Kerala, in southern India, where this study
was done, has a high prevalence of tropical pancreatitis.12,13 In our
series 25% patients with chronic calciﬁc pancreatitis were <30
years and had no history of alcohol consumption. The early onset of
disease, slow progression, and relatively long survival exposes
these individuals to the risk of frequent acute exacerbation,
vascular complications, and malignancy.
It is common for pseudoaneurysms in the pancreatico-duodenal
arcade to ﬁll from both ends of the arcade (gastroduodenal artery
and inferior pancreatico-duodenal artery). The goal of treatment is
to prevent pseudoaneurysm ﬁlling. This is achieved by coiling the
feeding arteries. If the pseudoaneurysm ﬁlls only from a single ar-
tery, coiling of this artery (inﬂow occlusion) is sufﬁcient. However,
trapping the pseudoaneurysm by coiling feeders from both ends of
the arcade is usually required. This can be achieved by eitherdigital subtraction angiography (DSA) shows the pseudoaneurysm (arrowhead) arising
l cyanoacrylate failed because of arterio-portal shunting. Later, embolization was per-
sm under ultrasound guidance. (B) DSA following intra-operative embolization shows
l radicals (arrow).
Fig. 6. A 53-year-old male with chronic pancreatitis presented with abdominal pain. Contrast-enhanced computed tomography (CT) and celiac digital subtraction angiography
shows multiple intraparenchymal calciﬁcations (A, arrows) and pseudoaneurysm (B,C arrowhead) arising from the distal splenic artery (B,C arrow). (D) As distal access was not
achieved, direct intra-arterial N-butyl cyanoacrylate injection was performed with the microcatheter tip just proximal to the pseudoaneurysm (arrow). Note spillover of glue into
the distal splenic artery branches (small arrow). Post embolization DSA (E) and CT (F) shows glue cast (arrow head). (G) Contrast-enhanced CT 5 days later shows no reperfusion of
pseudoaneurysm (arrow head) and multiple splenic infarcts (arrow).
Chinmay Bhimaji Kulkarni et al. / Endovascular Management of Pancreatic Pseudoaneurysms 51separately accessing the feeding arteries from the gastroduodenal
artery (GDA) or superior mesenteric artery (SMA), or by crossing
the pseudoaneurysm through the initially accessed feeding artery
and then coiling distally. If the feeder from the opposite end of theFig. 7. A64-year-oldmalewith acutepancreatitis presentedwith acuteabdominal pain. (A)Co
image showing a pseudoaneurysm (arrowhead) arising from the superior mesenteric artery (S
deploying a covered stent across the neck of pseudoaneurysm (arrows). Postprocedure the SMarcade cannot be accessed, then directly embolizing the pseudoa-
neurysm intra-arterially with NBCA is an option. Alternatively the
accessed feeder can be coiled and subsequently treatment can be
completed with direct percutaneous NBCA injection. If the artery ofntrast-enhanced computed tomographycoronalvolumerendered technique reformatted
MA, arrow). (B) As the SMA is not expendable, isolation of pseudoaneurysm achieved by
A is patent and the pseudoaneurysm completely isolated (arrowhead).
Fig. 8. A 73-year-old female with acute pancreatitis presented with acute pain abdomen. (A) Digital subtraction angiography shows the pseudoaneurysm (arrowhead) arising from
the gastroduodenal artery (GDA). (B) Coil embolization of GDA (arrow). (C) However, pseudoaneurysm reperfused through multiple small distal feeders from the pancreatico-
duodenal arcade (arrowhead). (D) As these feeders were not accessible, percutaneous direct injection of N-butyl cyanoacrylate into the pseudoaneurysm was done under ultra-
sound guidance using a Chiba needle (D, arrow). (E) Note the reﬂux of glue into the distal feeders (arrow). (F) Follow-up computed tomography 10 months later showing no
reperfusion of the pseudoaneurysm (arrowhead).
Gastrointestinal Intervention 2014 3(1), 46–5352origin is not expendable, then the covered stent can be used to
exclude the pseudoaneurysms from systemic circulation.
In our study, coil embolization was the commonest technique
used to isolate the pseudoaneurysm. The trapping technique ach-
ieves complete isolation of pseudoaneurysm by occluding both
proximal and distal feeders to the pseudoaneurysm (Fig. 2). Inﬂow
occlusion although technically easy, requires a longer time to pro-
duce thrombosis and is associated with a high rate of reperfusion of
pseudoaneurysm through distal collaterals (Fig. 3).
Permanent occlusion of pseudoaneurysm can also be achieved
using liquid embolic agents such as NBCA or ethylene vinyl alcohol
copolymer. Low viscosity of liquid allows it to ﬁll both the pseu-
doaneurysm and collaterals in a single injection. NBCA can be
injected percutaneously under ultrasound guidance or through an
appropriately placed microcatheter. Izaki et al,14 in an analysis of 12
patients of pancreatitis-related pseudoaneurysm, used treatment
with NBCA which showed a success of 100%. Intra-arterial orFig. 9. Algorithm for endovascular managemenpercutaneous NBCA embolization can be done when difﬁcult anat-
omyprecludes coil trapping. Before injectingNBCA it is important to
ensure a safe microcatheter position either into or close to the
pseudoaneurysm. We used a 15–20% concentration of NBCA which
allowsﬁlling and complete exclusion of the pseudoaneurysm (Fig. 4,
5). At lower concentrations there is risk of spillage into nontarget
distal arteries (Fig. 6). Using a higher concentration carries a risk of
premature cast formation and inadequate ﬁlling of the pseudoa-
neurysm which can subsequently reperfuse through distal collat-
erals. The main concern with using NBCA either intra-arterial or
percutaneously is the risk of rupture secondary to increased pres-
sure within the pseudoaneurysm. The percutaneous approach in-
volves puncture through the wall of the pseudoaneurysm which
may be especially risky when the wall is friable. We found that a
signiﬁcant number of pseudoaneurysms occurring in a background
of chronic pancreatitis had thicker walls. This feature, we believe,
could make NBCA injection intra-arterially or percutaneously moret of pancreatitis-related pseudoaneurysms.
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access distal to pseudoaneurysm either by crossing it or gaining
access from the SMA. Especially in the pancreatico-duodenal arcade,
coilingeveryarterial supply to thepseudoaneurysmmaybedifﬁcult.
We ﬁnd that using NBCA reduces the procedure time and thereby
the radiation dose to the patient and staff. Comparedwith the use of
multiple coils, NBCA is also less expensive.
Covered stents have been used successfully for isolation of
pseudoaneurysm in nonexpendable arteries.15 The main advantage
of using a covered stent is the preservation of ﬂow in the parent
vessel (Fig. 7).
Coiling can be combined with either NBCA or gelfoam emboli-
zation to complete the treatment. Gelfoam is a safe, temporary
embolic agent which can be used in isolation or as an adjuvant to
other permanent agents to occlude multiple small efferent vascular
branches.16 A combination of techniques may be employed when
isolation is not achieved by a single method (Fig. 8).
Another widely used technique for occluding a pseudoaneur-
ysm is percutaneous direct injection of thrombin into the pseu-
doaneurysm under ultrasound or ﬂuoroscopy guidance. This is
mainly used for pseudoaneurysms not easily accessible via a
transcatheter technique and in which the feeding vessel cannot be
identiﬁed.17–19 We did not use thrombin in our patients as it is not
approved for use in our practice.
Endovascular treatment is effective in the management of
pancreatitis-related pseudoaneurysms and has good outcomes.
Which endovascular technique to use depends on the vascular
location and morphological features of the pseudoaneurysm
(Fig. 9). Pseudoaneurysms in the background of chronic pancrea-
titis tend to have thicker walls compared with pseudoaneurysms in
acute pancreatitis. Direct percutaneous or transcatheter NBCA in-
jection is probably safer in pseudoaneurysms with thicker walls.
Pseudoaneurysms in the pancreatico-duodenal arcade may require
a combination of coiling, NBCA injection, or gelfoam embolization
to achieve isolation from circulation.
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